Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
July 8, 2019 Off

Global Hemophilia Market Insights, Trends and Forecast Report (2019-2023) – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Hemophilia Market Report: Insights, Trends and Forecast (2019-2023)” report has been added to ResearchAndMarkets.com’s offering. The global…

July 8, 2019 Off

Sample Assortment Kits from Qosina Are the Perfect Prototyping Resource

By BusinessWire

RONKONKOMA, N.Y.–(BUSINESS WIRE)–#Qosina–Qosina is pleased to offer sample assortment kits in a wide variety of product categories. Each kit is…

July 8, 2019 Off

Sample Assortment Kits from Qosina Are the Perfect Prototyping Resource

By BusinessWire

RONKONKOMA, N.Y.–(BUSINESS WIRE)–#Qosina–Qosina is pleased to offer sample assortment kits in a wide variety of product categories. Each kit is…

July 8, 2019 Off

Global Natural Language Processing in Healthcare and Life Sciences Market to surpass US$ 21,347 Million by 2026

By BusinessWire

SEATTLE–(BUSINESS WIRE)–#NLP–According to Coherent Market Insights, the global natural language processing in healthcare and life sciences market was valued at…

July 8, 2019 Off

CEL-SCI Collaborators Presents Data for New Vaccine in the Treatment of Rheumatoid Arthritis at the International Conference on Immunity and Immunochemistry Meeting

By BusinessWire

Second Rheumatoid Arthritis vaccine discovered which acts alone and can complement the existing CEL-4000 Rheumatoid Arthritis vaccine in an animal…

July 8, 2019 Off

Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Worth $10.2 Billion by 2023 – Technavio

By BusinessWire

LONDON–(BUSINESS WIRE)–#Research–The global vascular endothelial growth factor inhibitors market size is poised to reach USD 10.2 billion by 2023, according…

July 8, 2019 Off

Vivacelle Bio, Inc. Announces FDA Clearance to Enroll Patients into a Phase IIa Clinical Trial of VBI-S for Elevation of Blood Pressure in Subjects Who Have Shock Due to Sepsis

By BusinessWire

CHICAGO–(BUSINESS WIRE)–Vivacelle Bio, Inc. announces that the US Food and Drug Administration (FDA) has granted Dr. Cuthbert Simpkins, MD its…

July 8, 2019 Off

RAPID Receives Registration Approval in Japan

By BusinessWire

RAPID, the only clinically validated, next-generation imaging platform for assessing ischemic stroke, now available in Japan MENLO PARK, Calif.–(BUSINESS WIRE)–#AI–iSchemaView,…

July 8, 2019 Off

Eurofins Acquires LAB Solution, Thereby Strengthening Its Footprint in the Textile and Leather Industries

By BusinessWire

BRUSSELS–(BUSINESS WIRE)–Eurofins Consumer Products Testing (CPT) is proud to announce the acquisition of LAB Solution S.r.l. The acquisition is a…

ObsEva wraps up patients recruitiment for testing linzagolix, to treat certain heavy menstrual bleeding
July 8, 2019 Off

ObsEva wraps up patients recruitiment for testing linzagolix, to treat certain heavy menstrual bleeding

By Dino Mustafić

ObsEva has completed recruiting patients for its Phase 3 clinical trial PRIMROSE 1 testing of oral gonadotropin releasing hormone (GnRH) receptor antagonist linzagolix for the treatment of heavy menstrual bleeding (HMB) associated with uterine fibroids (UF).

Posts pagination

Previous 1 … 3,023 3,024 3,025 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine